← Leaderboards
Saswati Chatterjee
City Of Hope National Medical Center
$4,059,760
Attributed
$5,711,125
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $842.6K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,711,125 · 5
By mechanism
R01$2,399,224 · 2
R42$1,923,411 · 1
P01$1,388,490 · 2
Top collaborators
- Nicole Bergman3 shared
- Yu-Chong Tai3 shared
- Vinodh Narayanan1 shared
Most similar at City Of Hope National Medical Center
Same institution · by research overlap
- John Joseph Rossi$25,916,442
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyCellsVectorGene Transduction AgentCellular TransductionCommunicable DiseasesViral VectorGene Transfer VectorInvestigationBaseHematopoietic Stem CellsToxic EffectEvaluationStem CellsGeneticTropismPathogenicityIn VivoLiverSafetyCell CycleModificationGenomeIn Vitro
Grant awards (12)
High Fidelity Genome Editing for the Correction of MECP2 Mutations and Physiologic Regulation of Expression in Rett Syndrome$738,182
R01 · FY2025 · NS · contact PI
High Density Cell Respirator (HDCR) for the production of vectors, viruses and vaccines$830,585
R42 · FY2022 · TR
High Density Cell Respirator (HDCR) for the production of vectors, viruses and vaccines$842,585
R42 · FY2021 · TR
High Density Cell Respirator (HDCR) for the production of vectors, viruses and vaccines$250,241
R42 · FY2020 · TR
Genetic Modification of Human Hematopoietic Stem Cells with Pseudotyped rAAV$415,000
R01 · FY2011 · HL · contact PI
Genetic Modification of Human Hematopoietic Stem Cells with Pseudotyped rAAV$415,000
R01 · FY2010 · HL · contact PI
Genetic Modification of Human Hematopoietic Stem Cells with Pseudotyped rAAV$415,000
R01 · FY2009 · HL · contact PI
Genetic Modification of Human Hematopoietic Stem Cells with Pseudotyped rAAV$416,042
R01 · FY2008 · HL · contact PI
AAV TRANSDUCTION OF QUIESCENT HEMATOPOIETIC STEM CELLS$347,123
P01 · FY2002 · HL
CORE--VECTOR$347,122
P01 · FY2002 · HL
AAV TRANSDUCTION OF QUIESCENT HEMATOPOIETIC STEM CELLS$347,123
P01 · FY2000 · HL
CORE--VECTOR$347,122
P01 · FY2000 · HL